HK1036630A1 - Peptides based on the sequence of human lactoferrin and their use - Google Patents

Peptides based on the sequence of human lactoferrin and their use

Info

Publication number
HK1036630A1
HK1036630A1 HK01107436A HK01107436A HK1036630A1 HK 1036630 A1 HK1036630 A1 HK 1036630A1 HK 01107436 A HK01107436 A HK 01107436A HK 01107436 A HK01107436 A HK 01107436A HK 1036630 A1 HK1036630 A1 HK 1036630A1
Authority
HK
Hong Kong
Prior art keywords
relates
human lactoferrin
peptides
sequence
peptides based
Prior art date
Application number
HK01107436A
Other languages
English (en)
Inventor
Hanson Lars
Mattsby-Baltzer Inger
Dolphin Gunnar
Original Assignee
Pharmasurgics In Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9802441A external-priority patent/SE9802441D0/xx
Priority claimed from SE9802562A external-priority patent/SE9802562D0/xx
Application filed by Pharmasurgics In Sweden Ab filed Critical Pharmasurgics In Sweden Ab
Publication of HK1036630A1 publication Critical patent/HK1036630A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
HK01107436A 1998-07-06 2001-10-24 Peptides based on the sequence of human lactoferrin and their use HK1036630A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9802441A SE9802441D0 (sv) 1998-07-06 1998-07-06 New peptides and use thereof
SE9802562A SE9802562D0 (sv) 1998-07-17 1998-07-17 New peptides and use thereof
SE9804614A SE9804614A0 (en) 1998-07-06 1998-12-29 New peptides and use thereof
PCT/SE1999/001230 WO2000001730A1 (en) 1998-07-06 1999-07-06 Peptides based on the sequence of human lactoferrin and their use

Publications (1)

Publication Number Publication Date
HK1036630A1 true HK1036630A1 (en) 2002-01-11

Family

ID=27355931

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01107436A HK1036630A1 (en) 1998-07-06 2001-10-24 Peptides based on the sequence of human lactoferrin and their use

Country Status (15)

Country Link
US (2) US7253143B1 (de)
EP (1) EP1095061B1 (de)
JP (2) JP4488622B2 (de)
AT (1) ATE381578T1 (de)
AU (1) AU752640B2 (de)
CA (1) CA2333306C (de)
CY (1) CY1108049T1 (de)
DE (1) DE69937798T2 (de)
DK (1) DK1095061T3 (de)
ES (1) ES2299253T3 (de)
HK (1) HK1036630A1 (de)
NZ (1) NZ509622A (de)
PT (1) PT1095061E (de)
SE (1) SE9804614A0 (de)
WO (1) WO2000001730A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
SE0200598D0 (sv) * 2002-02-27 2002-02-27 A & Science Invest Ab Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
US7323443B2 (en) 2002-12-12 2008-01-29 Agennix Inc. Lactoferrin in the reduction of pain
US8193310B2 (en) 2004-03-19 2012-06-05 The University Of Queensland Alpha helical mimics, their uses and methods for their production
US7183381B2 (en) 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
MX2008008548A (es) 2005-12-30 2008-09-10 Evonik Roehm Gmbh Peptidos utiles como petidos penetradores de celulas.
CA2657543C (en) * 2006-07-10 2017-03-07 Osterreichische Akademie Der Wissenschaften Antimicrobial peptides
WO2008089234A2 (en) 2007-01-16 2008-07-24 University Of Medicine And Dentistry Of New Jersey Natural polypeptides for oral health care
EP2050461A1 (de) * 2007-10-19 2009-04-22 PharmaSurgics in Sweden AB Peptide basierend auf der menschlichen Lactoferrinsequenz und ihre Verwendung
EP2060586A1 (de) * 2007-11-14 2009-05-20 PharmaSurgics in Sweden AB Neue synthetische Arginin-substituierte Peptide und ihre Verwendung
NZ590254A (en) 2008-06-09 2012-07-27 Palatin Technologies Inc Melanocortin receptor-specific cyclic peptides for treatment of sexual dysfunction
CN102271658B (zh) 2009-01-13 2013-06-12 佩加马公司 用于治疗伤口、瘢痕、外科手术后粘连形成的含有透明质酸的组合物
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
BR112012011787B1 (pt) 2009-11-23 2022-03-03 Palatin Technologies, Inc Peptídeo cíclico e composição farmacêutica
EA201290295A1 (ru) 2009-11-23 2013-01-30 Палатин Текнолоджиз, Инк. Специфичные к рецептору меланокортина-1 линейные пептиды
JP5177901B2 (ja) * 2009-12-02 2013-04-10 株式会社明治 栄養組成物
CN101891885B (zh) * 2010-08-18 2012-12-12 中国科学院长春应用化学研究所 聚丝氨酸酯及其制备方法
EP2481751A1 (de) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Humanem Lactoferrin abgeleitete Peptide
EP2771087A4 (de) * 2011-10-28 2015-06-10 Glycorex Transplantation Ab Verfahren zur extrakorporalen ausscheidung von einem oder mehreren bestandteilen aus blut
JP5763024B2 (ja) * 2012-09-07 2015-08-12 株式会社明治 栄養組成物
EP2989120A4 (de) * 2013-04-25 2017-04-19 Carmel-Haifa University Economic Corp. Synthetische entzündungshemmende peptide und verwendungen davon
US9856496B2 (en) 2013-12-12 2018-01-02 Life Technologies Corporation Membrane-penetrating peptides to enhance transfection and compositions and methods for using same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
WO1993014640A1 (en) 1992-01-23 1993-08-05 Morinaga Milk Industry Co., Ltd. Antibacterial agent and treatment of article therewith
JP3312946B2 (ja) * 1993-03-04 2002-08-12 雪印乳業株式会社 ウイルス感染・増殖抑制剤
JP3347819B2 (ja) 1993-06-28 2002-11-20 森永乳業株式会社 抗菌性ペプチドの精製方法
JP3529423B2 (ja) 1994-04-01 2004-05-24 森永乳業株式会社 抗菌性ペプチドの製造方法
JP3738042B2 (ja) 1994-05-17 2006-01-25 森永乳業株式会社 非経口用抗腫瘍剤
JP3812957B2 (ja) 1994-08-02 2006-08-23 森永乳業株式会社 角膜損傷治療剤
JP3506274B2 (ja) 1994-09-01 2004-03-15 雪印乳業株式会社 新規ペプチドおよび免疫賦活剤
JPH08143468A (ja) 1994-11-17 1996-06-04 Morinaga Milk Ind Co Ltd 抗潰瘍剤
JP3830179B2 (ja) * 1995-07-31 2006-10-04 森永乳業株式会社 抗寄生虫剤
JPH09165342A (ja) 1995-12-14 1997-06-24 Morinaga Milk Ind Co Ltd 抗真菌剤
EP0920331A1 (de) * 1996-08-12 1999-06-09 A+ Science Invest AB Behandlung und verhütung von infektionen, entzündungen und/oder tumoren mit hilfe von lactoferrin und /oder lactoferricin
JPH1059864A (ja) * 1996-08-15 1998-03-03 Morinaga Milk Ind Co Ltd 経口がん転移抑制剤
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof

Also Published As

Publication number Publication date
AU5076099A (en) 2000-01-24
DE69937798D1 (de) 2008-01-31
AU752640B2 (en) 2002-09-26
CA2333306A1 (en) 2000-01-13
SE9804614D0 (sv) 1998-12-29
JP2010090162A (ja) 2010-04-22
CY1108049T1 (el) 2012-05-23
US20080299180A1 (en) 2008-12-04
US7253143B1 (en) 2007-08-07
JP2002519438A (ja) 2002-07-02
SE9804614L (de) 1900-01-01
US7803757B2 (en) 2010-09-28
ES2299253T3 (es) 2008-05-16
WO2000001730A1 (en) 2000-01-13
DE69937798T2 (de) 2009-04-30
CA2333306C (en) 2011-12-06
SE9804614A0 (en) 2000-01-07
ATE381578T1 (de) 2008-01-15
DK1095061T3 (da) 2008-04-21
NZ509622A (en) 2003-05-30
JP4488622B2 (ja) 2010-06-23
EP1095061A1 (de) 2001-05-02
EP1095061B1 (de) 2007-12-19
PT1095061E (pt) 2008-03-10

Similar Documents

Publication Publication Date Title
HK1036630A1 (en) Peptides based on the sequence of human lactoferrin and their use
MY111177A (en) Flavour-masked pharmaceutical compositions
WO2002047703A8 (en) Immune system stimulation
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
HK1014159A1 (en) Therapeutic uses of bactericidal/permeability-increasing protein dimer products
WO2001072262A3 (en) New cosmetic, personal care, cleaning agent, and nutritional supplement compositions comprising bioactive glass and methods of making and using the same
AU4770596A (en) Improved therapeutic compositions comprising bactericidal/permeability-increasing (bpi) protein products
GB2288732B (en) Pharmaceutical compositions
BG101118A (en) Therapeutical compounds
HUP0302370A2 (hu) Javított, bioaktív savóprotein-hidrolizátum
EP0971717A4 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
AU3909497A (en) Anti-chlamydial methods and materials
AU4073901A (en) Novel pharmaceutical or dietetic mushroom-based compositions
MXPA01012641A (es) Composicion que comprende esfingomielinasa alcalina para uso como una preparacion dietetica, suplemento alimenticio o producto farmaceutico.
DE60025026D1 (de) Antimicrobielle wirkung des ersten kationischen cluster des menschlichen lactoferrins
HU9600887D0 (en) Compounds for medicinal use
WO1996022305A3 (en) Modified peptides
IL141325A0 (en) Tan-1057 derivatives
YU45103A (sh) Upotreba sarp/1 za lečenje i prevenciju skleroderme
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
UA84832C2 (ru) Остеопротегерин, его применение для изготовления фармацевтической композиции и получения пищевого продукта и корма для животных
ZA200002422B (en) An anti-parasitic food product and it's use in the treatment of parasitic infections.
ATE247961T1 (de) Sufentanilhaltige arzneimittel mit verzögerter wirkstoffabgabe
WO2000029433A3 (en) 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines
TH48959EX (th) ขวด

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20190705